Comments invited on the ICHE2CR2 guideline on periodic benefit risk evaluation report (PBRER).
The deadlines for comments is 21 May 2012.
Join Scoop.it for Free
Share ideas that matter on the social web and experience
the benefits of curating the world's best content.
I don't have a Facebook, a Twitter or a LinkedIn account
Already have an account: Login
L'actualité réglementaire de la pharmacovigilance en Europe
Curated by
EVELYNE PIERRON
 Your new post is loading...
No comment yet.
Sign up to comment
Delete the scoop?
Are you sure you want to delete this scoop?
Yes
|
